Barclays analyst Carter Gould raised the firm’s price target on Gilead (GILD) to $95 from $84 and keeps an Equal Weight rating on the shares. The company delivered a Q3 beat and raise, helped by Veklury but also Biktarvy, the analyst tells investors in a research note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Gilead Sciences Shows Strong Q3 Results Amid Strategic Initiatives
- Closing Bell Movers: AppLoving up 29% after Q3 earnings beat
- Gilead reports Q3 adjusted EPS $2.02, consensus $1.55
- Gilead raises FY24 EPS view to $4.25-$4.45 from $3.60-$3.90, consensus $3.81
- Notable companies reporting after market close